Havrix AD1 (440 IU) – Adult Hepatitis A Vaccine

Havrix AD1 is an inactivated hepatitis A vaccine designed to protect adults (16 years and older) from the hepatitis A virus. The vaccine is highly effective and provides long-lasting immunity following a single dose. It is recommended for individuals traveling to endemic areas, those with chronic liver diseases, healthcare professionals, and anyone at increased risk of exposure to hepatitis A.

🔹 Who Should Get Havrix AD1?

Adults traveling to countries with a high risk of hepatitis A
Healthcare workers and individuals in close contact with patients
Individuals with chronic liver conditions (cirrhosis, hepatitis B, hepatitis C)
Food handlers and individuals working in public services
People living in or planning to visit high-risk areas (Asia, Africa, Latin America)
Homosexual men and people who inject drugs
🔹 Key Benefits:
✔ Provides long-lasting protection against hepatitis A virus
✔ Safe and effective for adults (16 years and older)
✔ Highly recommended for travelers to hepatitis A-endemic regions
✔ Prevents liver disease, jaundice, and other complications caused by HAV
✔ Offers immunity for up to 25 years with a single dose

🔹 Indications:

Prevention of hepatitis A for adults at high risk
Travel vaccine for individuals visiting regions with poor sanitation
Protection for those with chronic liver disease or compromised immunity
Recommended for healthcare workers and those in close contact with infected individuals
⚠️ Precautions:

Must be administered under medical supervision
Common side effects: pain at the injection site, mild fever, headache, fatigue
Not recommended for individuals with severe allergic reactions to any component of the vaccine
Pregnant women and breastfeeding mothers should consult a doctor before administration
📦 Packaging: 1 dose (190,000)